On 18 April 2024, Josh Miller joined the featured on Category Visionaries podcast. In a candid reflection on the highs and lows of entrepreneurship, Josh Miller humorously suggests that every founder should consider therapy to navigate the emotional whirlwind that accompanies building and scaling a business, his career trajectory, and how Gradient Health Inc is democratizing access to medical imaging data.
Having experienced first hand the challenges of building a successful startup, FarmShots, now acquired by Syngenta and acting as the CEO of Gradient Health Inc, Josh gives some light-hearted advice: get a good therapist. He spoke about the sale of FarmShots as a landmark event, filled with a blend of intense emotions and surreal experiences. He shares anecdotes about the exit process, including the ironic moment of feeling financially strained despite the imminent wealth from the sale—a humorous yet poignant reminder of the unpredictable nature of startup exits.
Josh’s professional trajectory is a testament to his ability to harness technology in solving complex problems across diverse fields. At Farm Shots, he utilized satellite imagery to detect diseases in crops, demonstrating an early knack for innovative solutions. This experience paved the way for his later ventures into medical imaging, where he now leverages similar technologies to aid AI applications at Gradient Health. Josh is committed to democratizing access to medical imaging data, a critical component for advancing AI in healthcare. This mission reflects his ongoing commitment to using technology to bridge gaps in healthcare access and innovation.
Josh also draws intriguing parallels between his work in agricultural and medical imaging, noting the similarities in identifying diseases in crops and tumors in patients. This unique perspective showcases his holistic approach to technology application—finding common threads in seemingly disparate industries to innovate and solve pressing challenges.
Listen to the podcast on Spotify, Apple Podcasts, and Frontlines.
